Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... treatment (OST) on opioid-dependent individuals with human immunodeficiency virus (HIV) infection is well documented, especially with regard to adherence to highly active ... According to a study from Marseille, France, "The positive impact of opioid substitution treatment (OST) on opioid-dependent individuals with human ...
2009 NOV 23 ... "Human immunodeficiency virus type 1 (HIV-1)-specific T-cell reactivity has been related to protection from disease progression. ... CD8(+) and CD4(+) T cells stimulated by HIV-1 peptide-loaded, mature DC, defined as positive by intracellular staining for more than one immune mediator (IFN-gamma, interleukin 2, ...
2009 NOV 23 ... Country:South Africa, AIDS, Acquired Immune Deficiency Syndrome, Antivirals, HIV, Human Immunodeficiency Virus, Immune Reconstitution Inflammatory Syndrome, Immunology, ... according to whether they were paradoxical or unmasking in presentation. We measured positive, negative, and chance-corrected agreement (kappa) with expert opinion for CD1 and CD2, ...
2009 NOV 28 ... "Although HIV program evaluations focusing on mortality on ART provide important evidence on treatment ... of this study was to measure mortality that occurs both pre-ART and during ART among HIV-positive children enrolled in two HIV-programs in Cambodia," scientists writing in the journal ...
2009 NOV 23 ... "We examined sexually transmitted infection (STI), HIV, and hepatitis virus prevalence and risk behaviors among truck drivers. We asked ... drug use in the previous year, and 11% reported having ever injected drugs. tested positive as follows: 54 for HCV antibodies (8.5%), 66 for hepatitis B anticore (anti-HBc) ...
2009 NOV 23 ... with men (MSM). A community-based, cross-sectional sample of 1211 HIV negative and 251 HIV positive MSM was recruited in San Francisco in 2004 by time-location sampling." ...
2009 NOV 23 ... from the hit reality television series "Project Runway," who has been living with HIV for more than 20 years, launched a new "Living Positive By Design: Creating Positive ...
2009 NOV 23 ... the unique child-centered methodology behind Plan's many successes in the areas of HIV/AIDS, Tsunami recovery, malaria, nutrition, and water and sanitation. Plan ... participation of children and the entire community, have a greater chance of yielding positive results, especially for the long term," says Tam. Another Plan project ...
2009 NOV 23 ... warned in advance of World AIDS Day. Efforts to prevent mother-to-baby transmission of HIV must be urgently scaled up in high-prevalence countries to avoid needless infection of ... that by testing women and providing ARV treatment during pregnancy and labor for HIV-positive mothers, it's possible to prevent babies from being born with the virus," said Robert ...
2009 NOV 23 ... to a study from Seville, Spain, "The current validated assay to determine tropism of HIV variants is Trofile ®, which has some limitations. The aim of this work was to ... was performed in MCT group patients. The maraviroc clinical test (MCT) was considered positive if viral load was undetectable (<40 HIV-RNA copies/mL) or a reduction >= 1 log(10) ...
2009 NOV 23 ... According to recent research from the United States, "Human immunodeficiency virus-1 (HIV-1) infection may produce neurological deficits, such as cognitive decline, that may be ... The researchers concluded: "That EtOH abuse and/or dependence in HIV-positive individuals may promote HIV-1-associated cognitive deficits by altering NMDA receptor ...
2009 NOV 23 ... lymphoma that is most commonly seen in patients with human immunodeficiency virus (HIV) infections. The authors report a rare case of PBL in the oral cavity or a 40-year-old ... the oral cavity or a 40-year-old mail with HIV." "The lymphoma cells were positive for leukocyte common antigen, CD79a, CD138, Epstein-Barr virus (EBV) and kappa light ...
2009 NOV 23 ... Current study results from the report, 'Laryngeal squamous cell carcinoma in HIV-positive patients: lack of association with human papillomavirus infection,' have been ...
2009 NOV 23 ... tuberculosis (TB) patients. However, the rate of recurrence has increased mainly due to HIV infection," scientists writing in the journal BMC Public Health report. ... "Decentralization of DOTS has increased the number of cured smear-positive tuberculosis (TB) patients. However, the rate of recurrence has increased mainly due to ...
2009 NOV 17 ... studies on the molecular biology of this behavior, however." "We used an HIV-based lentivirus to produce germline transgenic zebra finches. The lentivirus encoded ... the F1 generation transgenics have since reproduced, one having five offspring (all GFP positive) and the other four offsping (one GFP positive)." Agate and colleagues ...
2009 NOV 23 ... drugs and to provide supportive community-based care for women identified as HIV positive during the trial. This obligation includes ensuring sustainable, post-trial access to ...
2009 NOV 23 ... history of STI, exchanging sex, using substances, having been tested for HIV and testing HIV positive. Anal intercourse is reported relatively less frequently than unprotected vaginal ...
2009 NOV 16 ... co-inventor of RTS,S and Vice President of R&D, Vaccines for Emerging Diseases and HIV, at GSK Biologicals. "The Phase III trial is a huge undertaking that ... to save the lives of hundreds of thousands of African children, if the data are positive," said Dr. Christian Loucq, director of the PATH Malaria Vaccine Initiative. "But ...
2009 NOV 16 ... first ever study using patients' cells carrying an engineered T cell receptor to treat HIV (SL9 HA-GAG-TCR). The trial may have important implications in the development of new ... using lentiviral vectors expressing high affinity gag-specific TCRs in patients who are positive for the tissue type HLA A02. The specific target of the TCR is the HIV-1 gag epitope SL9 ...
